Profile
At Amneal, we believe in reducing barriers to patients accessing the medicines they need most. That’s why we are committed to ensuring access to quality therapies. Amneal is committed to building and maintaining a meaningful presence in the oncology space with biosimilars and evolved formulations of buy-and-bill oncology therapies.
Amneal Pharmaceuticals, Inc. is a U.S specialty pharmaceutical company focused on developing, manufacturing and distributing a growing portfolio of generic, complex generic – including biosimilars - and branded products. Our colleagues deliver Quality and value for customers and patients primarily within the United States. Visit Amneal.com for more information.